Latest ArticlesEpilepsy is a neurological disorder caused by abnormal neuronal discharges in the brain, characterized by a complex pathogenesis, and it is particularly prevalent among children, with approximately one-third of children with epilepsy still cannot effectively control their seizures. Lacosamide is a third-generation novel sodium channel blockers for anti-epileptic seizures. It has the advantages of rapid absorption, high bioavailability, biological equivalence among different formulations, and minimal drug interactions. Currently, it is approved for monotherapy or combination therapy for focal seizures in children aged 4 and above. This article reviewed the anti-epileptic mechanism, pharmacokinetics, monotherapy and combination therapy feedback of lacosamide, aiming to provide a reference for the selection of treatment plans for childhood epilepsy.
Chronic obstructive pulmonary disease(COPD) is a globally prevalent chronic inflammatory airway disease, for which current clinical interventions remain limited in effectively halting its progression. In recent years, the metabolic-immune linkage has emerged as a critical breakthrough in elucidating COPD pathogenesis. This article reviewed research progress on lipid metabolic reprogramming, immune cell metabolic dependencies, and aberrant signaling pathways in COPD, with amphasis on the interplay between metabolic pathways-such as adenosine monophosphate-activated protein kinase, sirtuin 1, and peroxisome proliferator-activated receptor γ-with immune regulation, and assessed the current targeted therapeutic strategies and drug development, aiming to provide theoretical insights for future mechanistic studies and clinical translation, thereby broadening the landscape for precision therapy in COPD.
Morphine is widely used as a potent analgesic in clinical practice. However, tolerance resulting from its long-term use poses a major challenge in pain management. The development of morphine tolerance involves numerous complex regulatory mechanisms characterized by intricate interactions and a lack of specific therapeutic targets. Current research on interventions for morphine tolerance remains largely at an early stage, making clinical translation and application difficult in the near term. Consequently, effective clinical strategies are still lacking. This review summarizes the current understanding of mechanisms underlying morphine tolerance, aiming to provide insights for future research and therapeutic development.
Esketamine, an N-methyl-D-aspartate receptor antagonist, is widely used in clinical anesthesia and analgesia. It is characterized by rapid onset, fast metabolism, and minimal respiratory suppression. Due to physiological deterioration of systemic organ function, comorbidities with chronic diseases, and reduced drug metabolism in elderly patients, esketamine, with its stable effect on hemodynamics, has become an ideal drug for perioperative anesthesia management. The tolerance of esketamine in the cardiovascular and respiratory systems of elderly patients is significantly better than that of traditional anesthetics(such as propofol and opioids), and its unique antidepressant effect provides additional clinical value for the elderly who are prone to emotional disorders after surgery. However, the physiological characteristic of cognitive decline in elderly patients requires vigilance against neurological adverse reactions such as delirium and hallucinations during its use. Although adverse reactions are controllable at reasonable doses, the safety of long-term use still needs further exploration. This article systematically discussed the pharmacokinetic characteristics, impact on multiple systems, clinical applications and safety of esketamine in differernt surgical scenarios in the elderly, and put forward future research directions to provide reference for clinical practice.
To explore the potential mechanism of cardiotoxicity inducing by tyrosine kinase inhibitors(TKI) in human-derived cells.
Using real-time cell analysis technology to assess the effects of three TKI drugs with different targets and different concentrations-lapatinib, dasatinib and osimertinib-on the functional indicators of human induced pluripotent stem cell-derived cardiomyocytes(hiPSC-CMs). Using automated patch clamp technique to investigate the effects of TKI drugs lapatinib, dasatinib and osimertinib on the potassium channel current of human ether-a-go-go related gene(HERG) in human embryonic kidney HEK293 cells.
Compared with the negative control group, lapatinib at concentration≥10 μmol/L significantly inhibit the beating signals of hiPSC-CMs. The half maximal inhibitory concentration(IC50) for the beating of hiPSC-CMs was 7.20 μmol/L, and the IC50 for the HERG potassium channel current in HEK293 cells was 3.92 μmol/L. Compared with the negative control group, dasatinib at concentration 30 μmol/L significantly inhibit the beating signal of hiPSC-CMs. The IC50 for the beating of hiPSC-CMs was 16.00 μmol/L, and the IC50 for the HERG potassium channel current of HEK293 cells was 12.18 μmol/L. Compared with the negative control group, osimertinib at concentration≥3 μmol/L significantly inhibit the beating signal of hiPSC-CMs. The IC50 for the beating of hiPSC-CMs was 2.60 μmol/L, and the IC50 for the HERG potassium channel current of HEK293 cells was 2.06 μmol/L.
Three kinds of TKI drugs with different targets can inhibit the beating and potassium channels of two kinds of human derived cells, providing data support for the subsequent basic research of human cardiomyocytes.
To explore the effect of Yishen Ningxin decoction(YSNX) on circadian rhythm behavior in zebrafish sleep deprivation model and its potential mechanism.
The zebrafish sleep deprivation model was established by light exposure method. The zebrafish behavioral analysis system was used to collect and analyze the 36 h circadian moving distance, moving time and sleeping time of zebrafish. Enzyme linked immunosorbent assay was used to measure the circadian expression levels of 5-hydroxytryptamine(HT) and 5-HT receptor(HTR) 1A at five time points during the observation period. The quantitative polymerase chain reaction was used to detect the relative expression levels of htr1aa messenger RNA(mRNA) and htr1ab mRNA.
Compared with the model group, both day and night moving distance and moving time in YSNX high-dose group decreased, while sleeping time increased. The circadian rhythm of average moving distance of zebrafish in YSNX high-dose group was restored to the level similar to that in the blank group. Compared with the model group in the same period, the level of 5-HT in zebrafish in YSNX group increased during the daytime period and decreased during the night period, the level of HTR1A decreased during the daytime period and increased during the night period, the average relative expression level of htr1aa mRNA decreased during the daytime period while that of htr1ab mRNA increased during the night period. Compared with the same time point in the model group, the content of 5-HT in YSNX group increased at all time points during the day, but decreased at all time points during the night, the HTR1A content decreased at all time points during the day, but increased at all time points during the night, the relative expression level of htr1aa mRNA decreased at zeitgeber time(ZT)14 and ZT20 on the first day and increased at ZT2 on the second day, while that of htr1ab mRNA increased at ZT2 on the second day.
Yishen Ningxin decoction may improve sleep-wake circadian rhythm in sleep-deprived zebrafish by regulating the circadian rhythm of 5-HT, HTR1A, htr1aa mRNA and htr1ab mRNA.
To observe the effect of oxycodone combined with fascia iliaca compartment block on postoperative rehabilitation quality of elderly patients with intertrochanteric fracture.
A total of 90 elderly patients with femoral intertrochanteric fractures admitted to Qingdao Huangdao District Central Hospital from January 2022 to December 2023 were selected. They were divided into control group and experimental group by simple random sorting method, with 45 cases in each group. All patients were treated with proximal femoral nail anti-rotation internal fixation, and underwent ultrasound-guided fascia iliaca compartment block under general anesthesia. The control group was given sufentanil 0.1 μg/kg, and the experimental group was given oxycodone 1 mg. The recovery time, laryngeal mask extraction time, post-anesthesia care unit(PACU) stay time, hospitalization time, full weight-bearing time and fracture healing time were compared between the two groups. The visual analogue scale(VAS), Harris hip score(HHS), serum levels of C-reaction protein(CRP), interleukin-6 (IL-6) and tumor necrosis factor-α(TNF-α) were compared between the two groups at 2 h and 48 h after operation. The incidence of adverse reactions was compared between the two groups.
The recovery time, laryngeal mask time and PACU stay time of the experimental group were all shorter than those of the control group(P<0.05). At 48 h after operation, the VAS scores of the two groups were significantly lower than those at 2 h(P<0.05), and the HHS were higher than those at 2 h after operation(P<0.05). At 48 h after operation, the VAS score of the experimental group was lower than that of the control group(P<0.05), and the HHS was higher than that of the control group(P<0.05). The serum levels of CRP, IL-6 and TNF-α in both groups at 48 h after operation were lower than those at 2 h after operation(P<0.05). The serum levels of CRP, IL-6 and TNF-α in the experimental group were all lower than those in the control group at 2 h and 48 h after operation(P<0.05). The hospitalization time of the experimental group was significantly shorter than that of the control group(P<0.05). There was no significant difference in adverse reactions between the two groups(P>0.05).
Oxycodone combined with fascia iliaca compartment block for elderly patients with intertrochanteric fracture can alleviate pain, reduce inflammation response, minimize adverse reactions, and help postoperative rehabilitation.
To investigate the impact of osimertinib targeted therapy on short-term efficacy in patients with epidermal growth factor receptor(EGFR)-mutated advanced non-small cell lung cancer(NSCLC).
A retrospective analysis was conducted on clinical data from 134 patients with EGFR-mutated advanced NSCLC admitted to our hospital from December 2023 to March 2025. Patients were divided into a control group(pemetrexed+cisplatin chemotherapy, n=64) and a combination group(osimertinib+pemetrexed+cisplatin chemotherapy, n=70) according to the actual treatment received. The short-term efficacy, serum tumor markers [carcinoembryonic antigen(CEA), cytokeratin 19 fragment antige(Cyfra) 21-1, neuron-specific enolase(NSE)], angiogenesis indicators[vascular endothelial growth factor(VEGF), matrix metalloproteinase(MMP)-9, cytosolic thymidine kinase(TK)1], and adverse reactions were compared between the two groups. Based on the Kaplan-Meier survival curve, the overall survival(OS) and progression-free survival(PFS) were compared.
After treatment, the disease control rate(DCR) in the combination group was higher than that in the control group(90.00% vs. 75.00%, P<0.05). Serum levels of CEA, Cyfra21-1, NSE, VEGF, MMP-9, and TK1 in the combination group were significantly lower than those in the control group(P<0.05). There was no statistically significant difference in adverse reactions between the two groups(P>0.05). The survival functions of OS and PFS in the combination group were better than those in the control group(χ2=4.720, 5.014, P=0.030, 0.025).
Osimertinib targeted therapy for patients with advanced NSCLC with EGFR mutations can significantly reduce serum tumor markers and angiogenesis indicators, improves DCR, OS rate, and prolong the median PFS period, and does not significantly increase the adverse reactions.